Publication | Open Access

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

MedicineTumor BuddingPathologyColorectal CancerPost-hoc AnalysisIndependent Prognostic FactorCancer TreatmentOncologyRadiation OncologyCancer ResearchCancer Growth